PURPOSE: To analyze the difference in the distribution of an insulin growth factor-1 (IGF-1) polymorphism (-2995 C/A) between young and old colorectal cancer (CRC) patients. METHODS: Information from 950 CRC patients undergoing surgery at the Taipei Veterans General Hospital between 2000 and 2005 was collected. The IGF-1 polymorphism was analyzed in patients in extreme age ranges at the time of CRC onset (i.e., under the 20th and above the 80th percentiles, respectively). Associations between clinicopathological variables and the IGF-1 polymorphism were analyzed. RESULTS: Young CRC patients had a higher frequency of advanced disease (58.7%) and mucinous adenocarcinoma (20%) than old CRC patients. Among old CRC patients, the frequency of the AA genotype of IGF-1 was 12.7% (24/189), which was significantly higher than in young patients (4.2%). Other clinicopathological factors including tumor location, differentiation, lymphovascular invasion, and TNM stage were not associated with the AA genotype of IGF-1. Mucinous differentiation (but not the other clinicopathological factors) was significantly associated with the CA/AA genotype of IGF-1 (39/195). CONCLUSIONS: Older patients had a higher frequency of the AA genotype of IGF-1(-2995 C/A), while younger patients more often had advanced disease and mucinous adenocarcinoma.
PURPOSE: To analyze the difference in the distribution of an insulin growth factor-1 (IGF-1) polymorphism (-2995 C/A) between young and old colorectal cancer (CRC) patients. METHODS: Information from 950 CRCpatients undergoing surgery at the Taipei Veterans General Hospital between 2000 and 2005 was collected. The IGF-1 polymorphism was analyzed in patients in extreme age ranges at the time of CRC onset (i.e., under the 20th and above the 80th percentiles, respectively). Associations between clinicopathological variables and the IGF-1 polymorphism were analyzed. RESULTS: Young CRCpatients had a higher frequency of advanced disease (58.7%) and mucinous adenocarcinoma (20%) than old CRCpatients. Among old CRCpatients, the frequency of the AA genotype of IGF-1 was 12.7% (24/189), which was significantly higher than in young patients (4.2%). Other clinicopathological factors including tumor location, differentiation, lymphovascular invasion, and TNM stage were not associated with the AA genotype of IGF-1. Mucinous differentiation (but not the other clinicopathological factors) was significantly associated with the CA/AA genotype of IGF-1 (39/195). CONCLUSIONS: Older patients had a higher frequency of the AA genotype of IGF-1(-2995 C/A), while younger patients more often had advanced disease and mucinous adenocarcinoma.
Authors: Temitope O Keku; Adriana Vidal; Shannon Oliver; Catherine Hoyo; Ingrid J Hall; Oluwaseun Omofoye; Maya McDoom; Kendra Worley; Joseph Galanko; Robert S Sandler; Robert Millikan Journal: Cancer Causes Control Date: 2012-05-08 Impact factor: 2.506
Authors: Zhuoyu Sun; Lin Liu; Peizhong Peter Wang; Barbara Roebothan; Jin Zhao; Elizabeth Dicks; Michelle Cotterchio; Sharon Buehler; Peter T Campbell; John R McLaughlin; Patrick S Parfrey Journal: Nutr J Date: 2012-03-26 Impact factor: 3.271
Authors: Reema F Tayyem; Hiba A Bawadi; Ihab N Shehadah; Suhad S Abu-Mweis; Lana M Agraib; Kamal E Bani-Hani; Tareq Al-Jaberi; Majed Al-Nusairr; Dennis D Heath Journal: Nutrients Date: 2015-03-10 Impact factor: 5.717